These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20229049)

  • 1. Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project.
    Paget WJ; Balderston C; Casas I; Donker G; Edelman L; Fleming D; Larrauri A; Meijer A; Puzelli S; Rizzo C; Simonsen L;
    Eur J Pediatr; 2010 Aug; 169(8):997-1008. PubMed ID: 20229049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
    Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
    Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of increased influenza vaccination in 2-3-year-old children on disease burden within the general population: A Bayesian model-based approach.
    Rajaram S; Wiecek W; Lawson R; Blak BT; Zhao Y; Hackett J; Brody R; Patel V; Amzal B
    PLoS One; 2017; 12(12):e0186739. PubMed ID: 29244811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
    Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
    Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season.
    Castilla J; Navascués A; Fernández-Alonso M; Reina G; Albéniz E; Pozo F; Álvarez N; Martínez-Baz I; Guevara M; García-Cenoz M; Irisarri F; Casado I; Ezpeleta C;
    Euro Surveill; 2016 Jun; 20(22):. PubMed ID: 27277013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011.
    Savulescu C; Jiménez-Jorge S; Delgado-Sanz C; de Mateo S; Pozo F; Casas I; Larrauri A;
    Vaccine; 2014 Jul; 32(35):4404-4411. PubMed ID: 24968153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for influenza--United States, 1997-98, 1998-99, and 1999-00 seasons.
    Brammer TL; Murray EL; Fukuda K; Hall HE; Klimov A; Cox NJ
    MMWR Surveill Summ; 2002 Oct; 51(7):1-10. PubMed ID: 12418623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving influenza virological surveillance in Europe: strain-based reporting of antigenic and genetic characterisation data, 11 European countries, influenza season 2013/14.
    Broberg E; Hungnes O; Schweiger B; Prosenc K; Daniels R; Guiomar R; Ikonen N; Kossyvakis A; Pozo F; Puzelli S; Thomas I; Waters A; Wiman Å; Meijer A
    Euro Surveill; 2016 Oct; 21(41):. PubMed ID: 27762211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study.
    Kissling E; Valenciano M; Larrauri A; Oroszi B; Cohen JM; Nunes B; Pitigoi D; Rizzo C; Rebolledo J; Paradowska-Stankiewicz I; Jiménez-Jorge S; Horváth JK; Daviaud I; Guiomar R; Necula G; Bella A; O'Donnell J; Głuchowska M; Ciancio BC; Nicoll A; Moren A
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seasonal influenza vaccine effectiveness against medically attended influenza illness among children aged 6-59 months, October 2011-September 2012: A matched test-negative case-control study in Suzhou, China.
    Wang Y; Zhang T; Chen L; Greene C; Ding Y; Cheng Y; Yang C; Zeng S; Hua J; Zhou S; Song Y; Luan L; Zhang J; Zhao G
    Vaccine; 2016 May; 34(21):2460-2465. PubMed ID: 27016650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic Drift of A/H3N2/Virus and Circulation of Influenza-Like Viruses During the 2014/2015 Influenza Season in Poland.
    Bednarska K; Hallmann-Szelińska E; Kondratiuk K; Brydak LB
    Adv Exp Med Biol; 2016; 905():33-8. PubMed ID: 26956457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16.
    Yaron-Yakoby H; Sefty H; Pando R; Dichtiar R; Katz MA; Stein Y; Mandelboim M; Mendelson E; Shohat T; Glatman-Freedman A;
    Euro Surveill; 2018 Feb; 23(7):. PubMed ID: 29471622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020.
    Rose A; Kissling E; Emborg HD; Larrauri A; McMenamin J; Pozo F; Trebbien R; Mazagatos C; Whitaker H; Valenciano M;
    Euro Surveill; 2020 Mar; 25(10):. PubMed ID: 32183932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the dynamics of seasonal influenza in Italy: incidence, transmissibility and population susceptibility in a 9-year period.
    Lunelli A; Rizzo C; Puzelli S; Bella A; Montomoli E; Rota MC; Donatelli I; Pugliese A
    Influenza Other Respir Viruses; 2013 May; 7(3):286-95. PubMed ID: 22694182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe.
    Kissling E; Rondy M;
    Euro Surveill; 2017 Feb; 22(7):. PubMed ID: 28230524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019.
    Kissling E; Rose A; Emborg HD; Gherasim A; Pebody R; Pozo F; Trebbien R; Mazagatos C; Whitaker H; Valenciano M;
    Euro Surveill; 2019 Feb; 24(8):. PubMed ID: 30808440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological and virological assessment of influenza activity in Europe, during the 2004-2005 winter.
    Meijer A; Paget WJ; Meerhoff TJ; Brown CS; Meuwissen LE; van der Velden J;
    Euro Surveill; 2006; 11(5):111-8. PubMed ID: 16757850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France.
    Pelat C; Falchi A; Carrat F; Mosnier A; Bonmarin I; Turbelin C; Vaux S; van der Werf S; Cohen JM; Lina B; Blanchon T; Hanslik T
    PLoS One; 2011 May; 6(5):e19621. PubMed ID: 21573005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological and virological assessment of influenza activity in Europe during the winter 2005-2006.
    Meijer A; Meerhoff TJ; Meuwissen LE; van der Velden J; Paget WJ;
    Euro Surveill; 2007 Sep; 12(9):E11-2. PubMed ID: 17991413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.